Spectrum Pharmaceuticals, Inc.

SPPINASDAQHealthcare

$1.03

$-0.01(-0.49%)

Market Cap$210377146

P/E Ratio—

52W High$1.57

52W Low$0.32

Avg Volume1.2M

Open$1.02

Beta2.14

Net Income Financials Revenue

Spectrum Pharmaceuticals, Inc. (SPPI) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

SPPI · net income · updated Jun 9, 2026

Core profitability metrics

SPPI · net income · margin · TTM · CAGR

Net income was −$78.1M for FY2022 (fiscal year ending 2022-12-31), up 50.7% year-over-year. Net profit margin was -772.2%. Based on available data, Spectrum Pharmaceuticals, Inc. has been profitable since at least 2011.

FY2022 Net Income−$78.1M▲ +50.7% YoY

Trailing 12M (TTM)−$65.1Mtrailing 4 quarters sum

Net Profit Margin-772.2%−$78.1M ÷ $10.1M

YoY Change+50.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · SPPI net income history · SPPI profit margin

Annual net income data

SPPI · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2022Loss−$78.1M▲ +50.7%-772.2%$10.1M

FY2021Loss−$158.4M▲ +7.5%—$0

FY2020Loss−$171.3M▼ 26.5%—$0

FY2019Loss−$135.4M▼ 12.8%-598.7%$22.6M

FY2018Loss−$120.0M▼ 31.5%-109.8%$109.3M

Net income vs peers (Healthcare)

SPPI vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Spectrum Pharmaceuticals, Inc.YOU

SPPI

−$78.1M+50.7%-772.2%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Spectrum Pharmaceuticals, Inc. (SPPI) reported net income of −$78.1M for FY2022 (fiscal year ending 2022-12-31), up 50.7% year-over-year. The net profit margin was -772.2% — meaning the company kept $-7.72 of every dollar of revenue as profit.

Based on available data, Spectrum Pharmaceuticals, Inc. has been profitable since at least 2011. Net income reached a peak of $94.5M in FY2012. Data available for 15 fiscal years.

Spectrum Pharmaceuticals, Inc.'s net profit margin was -772.2% for FY2022, based on the latest annual results.

Investors sometimes search for "Spectrum Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from SPPI net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

SPPI net income · 4 questions

Spectrum Pharmaceuticals, Inc. is not currently profitable on an annual basis. The company reported a net loss of $78.1M for FY2022.

is SPPI profitabledoes SPPI make a profitSPPI profitabilitySPPI profitable company

▸ Source: FMP /income-statement · GAAP · Spectrum Pharmaceuticals, Inc. · Spectrum Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026